Eyenovia Inc (EYEN)
0.7499
-0.07
(-8.65%)
USD |
NASDAQ |
May 17, 16:00
0.7499
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Total Liabilities (Quarterly): 24.36M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 24.36M |
December 31, 2023 | 19.78M |
September 30, 2023 | 19.09M |
June 30, 2023 | 18.82M |
March 31, 2023 | 13.50M |
December 31, 2022 | 13.80M |
September 30, 2022 | 11.08M |
June 30, 2022 | 12.00M |
March 31, 2022 | 10.39M |
December 31, 2021 | 11.19M |
September 30, 2021 | 20.75M |
June 30, 2021 | 21.59M |
March 31, 2021 | 16.71M |
December 31, 2020 | 18.60M |
Date | Value |
---|---|
September 30, 2020 | 7.197M |
June 30, 2020 | 3.108M |
March 31, 2020 | 2.583M |
December 31, 2019 | 2.957M |
September 30, 2019 | 2.478M |
June 30, 2019 | 2.418M |
March 31, 2019 | 2.568M |
December 31, 2018 | 3.140M |
September 30, 2018 | 1.732M |
June 30, 2018 | 1.280M |
March 31, 2018 | 1.123M |
December 31, 2017 | 0.5526M |
September 30, 2017 | 7.004M |
December 31, 2016 | 0.4237M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.418M
Minimum
Jun 2019
24.36M
Maximum
Mar 2024
12.62M
Average
12.75M
Median
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.197M |
Alpine Immune Sciences Inc | 40.94M |
Lantern Pharma Inc | 3.969M |
Oragenics Inc | 1.798M |
MAIA Biotechnology Inc | 14.48M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 26.18M |
Shareholders Equity (Quarterly) | 1.818M |
Debt to Equity Ratio | 8.205 |
Current Ratio | 0.878 |
Net Debt Paydown Yield | -2.65% |